Hemophilia therapy innovation: development of an advanced category recombinant factor VIII by a plasma/albumin-free method*1Proceedings of a special symposium at the XIXth Congress of the International Society on Thrombosis and Haemostasis, July 12–18, 2003, Birmingham, UK
- 1 April 2004
- journal article
- Published by Elsevier in Seminars in Hematology
- Vol. 41, 1-16
- https://doi.org/10.1016/s0037-1963(04)00017-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: